Publications by Year: 2002
2002
Maswadeh, H. ; Demetzos, C. ; Dimas, K. ; Loukas, Y. L. ; Georgopoulos, A. ; Mavromoustakos, T. ; Papaioannou, G. T. In-Vitro Cytotoxic/cytostatic Activity Of Anionic Liposomes Containing Vinblastine Against Leukaemic Human Cell Lines.
Journal of Pharmacy and Pharmacology 2002,
54, 189 - 196.
Website Tselios, T. ; Apostolopoulos, V. ; Daliani, I. ; Deraos, S. ; Grdadolnik, S. ; Mavromoustakos, T. ; Melachrinou, M. ; Thymianou, S. ; Probert, L. ; Mouzaki, A. ; et al. Antagonistic Effects Of Human Cyclic Mbp87-99 Altered Peptide Ligands In Experimental Allergic Encephalomyelitis And Human T-Cell Proliferation.
Journal of Medicinal Chemistry 2002,
45, 275 - 283.
Website Maswadeh, H. ; Demetzos, C. ; Daliani, I. ; Kyrikou, I. ; Mavromoustakos, T. ; Tsortos, A. ; Nounesis, G. A Molecular Basis Explanation Of The Dynamic And Thermal Effects Of Vinblastine Sulfate Upon Dipalmitoylphosphatidylcholine Bilayer Membranes.
Biochimica et Biophysica Acta - Biomembranes 2002,
1567, 49 - 55.
Website Roumelioti, P. ; Polevaya, L. ; Zoumpoulakis, P. ; Giatas, N. ; Mutule, I. ; Keivish, T. ; Zoga, A. ; Vlahakos, D. ; Iliodromitis, E. ; Kremastinos, D. ; et al. Design, Synthesis And Biological Evaluation Of Cyclic Angiotensin Ii Analogues With 3,5 Side-Chain Bridges: Role Of C-Terminal Aromatic Residue And Ring Cluster For Activity And Implications In The Drug Design Of At1 Non-Peptide Antagonists.
Bioorganic and Medicinal Chemistry Letters 2002,
12, 2627 - 2633.
Website Pispas, S. ; Siakali-Kioulafa, E. ; Hadjichristidis, N. ; Mavromoustakos, T. Block Copolymers With Crystalline/amorphous, Crystalline/polyelectrolyte And Amorphous/polyelectrolyte Blocks.
Macromolecular Chemistry and Physics 2002,
203, 1317 - 1327.
Website Apostolopoulos, V. ; Matsoukas, J. ; Plebanski, M. ; Mavromoustakos, T. Applications Of Peptide Mimetics In Cancer.
Current Medicinal Chemistry 2002,
9, 411 - 420.
Website Zoumpoulakis, P. ; Grdadolnik, S. G. ; Matsoukas, J. ; Mavromoustakos, T. Structure Elucidation And Conformational Properties Of Eprosartan A Non Peptide Angiotensin Ii At1 Antagonist.
Journal of Pharmaceutical and Biomedical Analysis 2002,
28, 125 - 135.
Website